VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 199 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,887,218 | -0.3% | 129,923 | +54.2% | 0.07% | -3.9% |
| Q1 2024 | $6,910,386 | +858.4% | 84,273 | +117.5% | 0.08% | +660.0% |
| Q4 2023 | $721,063 | +272.2% | 38,746 | +121.4% | 0.01% | +233.3% |
| Q3 2023 | $193,725 | +13.8% | 17,500 | +66.7% | 0.00% | 0.0% |
| Q2 2023 | $170,205 | -2.6% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $174,825 | +77.1% | 10,500 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $98,700 | +9770.0% | 10,500 | +2000.0% | 0.00% | – |
| Q3 2022 | $1,000 | -100.0% | 500 | -96.0% | 0.00% | -100.0% |
| Q1 2021 | $78,430,000 | +1960650.0% | 12,400 | +2154.5% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 550 | +83.3% | 0.00% | – |
| Q3 2019 | $2,000 | -77.8% | 300 | -72.7% | 0.00% | – |
| Q2 2019 | $9,000 | +80.0% | 1,100 | +266.7% | 0.00% | – |
| Q3 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |